Free Trial

Quince Therapeutics (QNCX) Institutional Ownership

Quince Therapeutics logo
$1.00 -0.05 (-4.29%)
As of 11:16 AM Eastern

Institutional Ownership Changes (13F Filings) for Quince Therapeutics (NASDAQ:QNCX)

Current
Institutional Ownership
Percentage
30.75%
Number of
Institutional Buyers
(last 12 months)
23
Total
Institutional Inflows
(last 12 months)
$282.98M
Number of
Institutional Sellers
(last 12 months)
4
Total
Institutional Outflows
(last 12 months)
$21.35M
Get QNCX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Quince Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

QNCX Institutional Buying and Selling by Quarter

Quince Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/18/2026 Superstring Capital Management LP858,711$2.88M1.5%N/A1.542%
2/18/2026 Quadrature Capital Ltd80,134$268K0.0%N/A0.144%
2/18/2026 Millennium Management LLC1,190,352$3.99M0.0%-14.2%2.138%
2/18/2026 683 Capital Management LLC238,177$798K0.0%N/A0.428%
2/17/2026 Almitas Capital LLC930,134$3.12M0.7%+88.0%1.670%
2/17/2026 Adage Capital Partners GP L.L.C.2,250,000$7.54M0.0%N/A4.041%
2/16/2026 OMERS ADMINISTRATION Corp92,000$308K0.0%N/A0.165%
2/13/2026 Nantahala Capital Management LLC2,672,429$8.95M0.3%-13.1%4.800%
2/13/2026 Marshall Wace LLP511,858$1.72M0.0%+143.7%0.919%
2/13/2026 Hudson Bay Capital Management LP63,471$213K0.0%N/A0.114%
2/12/2026 Jane Street Group LLC521,072$1.75M0.0%+1,382.0%0.936%
2/12/2026 Renaissance Technologies LLC538,100$1.80M0.0%+14.8%0.966%
2/11/2026 Cerity Partners LLC189,789$636K0.0%N/A0.341%
2/10/2026 Intellectus Partners LLC53,312$179K0.0%N/A0.096%
2/10/2026 Goldman Sachs Group Inc.229,695$769K0.0%N/A0.413%
2/9/2026 Geode Capital Management LLC523,899$1.76M0.0%+19.8%0.941%
11/17/2025 Nantahala Capital Management LLC3,073,729$5.01M0.2%+21.6%5.520%
11/17/2025 Millennium Management LLC1,386,776$2.26M0.0%+1,152.9%2.491%
11/17/2025 Almitas Capital LLC494,778$806K0.2%N/A0.889%
11/14/2025 ADAR1 Capital Management LLC775,034$1.26M0.1%+442.1%1.443%
11/14/2025 Shay Capital LLC136,955$223K0.0%-8.7%0.255%
11/14/2025 Bridgeway Capital Management LLC95,122$155K0.0%-26.0%0.177%
11/14/2025 Union Square Park Capital Management LLC224,746$366K0.1%+86.0%0.418%
11/7/2025 GSA Capital Partners LLP87,235$142K0.0%+158.0%0.162%
11/7/2025Vanguard Group Inc.1,763,387$2.87M0.0%+21.3%3.283%
8/15/2025 Shay Capital LLC150,000$248K0.0%-18.6%0.279%
8/15/2025 Bridgeway Capital Management LLC128,617$212K0.0%+20.9%0.239%
8/14/2025 Nantahala Capital Management LLC2,528,302$4.17M0.2%N/A4.707%
8/12/2025 XTX Topco Ltd22,660$37K0.0%N/A0.042%
8/8/2025 Rockefeller Capital Management L.P.169,554$280K0.0%N/A0.316%
5/14/2025Ieq Capital LLC806,780$1.07M0.0%N/A1.828%
5/12/2025Virtu Financial LLC43,332$58K0.0%+48.4%0.098%
4/11/2025Intellectus Partners LLC53,312$71K0.0%N/A0.121%
2/17/2025Two Sigma Investments LP30,341$57K0.0%N/A0.069%
2/17/2025Shay Capital LLC276,799$518K0.1%+60.8%0.629%
2/14/2025Northern Trust Corp50,524$94K0.0%+48.5%0.115%
2/12/2025Geode Capital Management LLC375,932$703K0.0%+10.9%0.854%
2/11/2025Virtu Financial LLC29,204$55K0.0%N/A0.066%
2/5/2025Anfield Capital Management LLC26,656$50K0.0%N/A0.061%
1/24/2025Scharf Investments LLC91,061$170K0.0%N/A0.207%
The REAL Reason Trump is Invading Iran (Ad)

For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.tc pixel

Click here to find out what it is.
11/16/2024Geode Capital Management LLC339,125$263K0.0%+24.2%0.784%
8/9/2024Renaissance Technologies LLC483,902$363K0.0%-7.0%1.120%
1/12/2024Scharf Investments LLC91,061$96K0.0%N/A0.212%
7/31/2023Intellectus Partners LLC53,527$81K0.0%N/A0.148%
7/24/2023BML Capital Management LLC1,411,839$2.13M1.9%N/A3.892%
5/11/2023EPIQ Capital Group LLC958,469$1.50M0.8%-9.3%2.642%
4/20/2023Hennion & Walsh Asset Management Inc.31,061$48K0.0%N/A0.086%


QNCX Institutional Ownership - Frequently Asked Questions

During the previous two years, 30 institutional investors and hedge funds held shares of Quince Therapeutics. The most heavily invested institutionals were Nantahala Capital Management LLC ($8.95M), Adage Capital Partners GP L.L.C. ($7.54M), Millennium Management LLC ($3.99M), Almitas Capital LLC ($3.12M), Superstring Capital Management LP ($2.88M), Vanguard Group Inc. ($2.87M), and Renaissance Technologies LLC ($1.80M).Learn more on Quince Therapeutics' institutional investors.

30.75% of Quince Therapeutics' stock is owned by institutional investors. Learn more on QNCX's institutional investor holdings.

Of the 30 institutional investors that purchased Quince Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Nantahala Capital Management LLC ($3.07M), Adage Capital Partners GP L.L.C. ($2.25M), Millennium Management LLC ($1.28M), Almitas Capital LLC ($930.13K), Superstring Capital Management LP ($858.71K), Ieq Capital LLC ($806.78K), and ADAR1 Capital Management LLC ($632.08K).

Institutional investors have bought a total of 11,592,232 shares in the last 24 months. This purchase volume represents approximately $282.98M in transactions.

The following institutional investors have sold Quince Therapeutics stock in the last 24 months: Nantahala Capital Management LLC ($401.30K), Millennium Management LLC ($196.42K), Shay Capital LLC ($47.38K), and Bridgeway Capital Management LLC ($33.50K).

Institutional investors have sold a total of 678,598 shares in the last 24 months. This volume of shares sold represents approximately $21.35M in transactions.



This page (NASDAQ:QNCX) was last updated on 6/3/2026 by MarketBeat.com Staff.
From Our Partners